Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$56.3M Buy
440,465
+81,454
+23% +$9.53M 0.74% 29
2026
Q1
$43.2M Buy
359,011
+90,581
+34% +$10.5M 0.91% 27
2025
Q4
$28.5M Sell
268,430
-3
-0% -$282 1.06% 28
2025
Q3
$22.7M Buy
268,433
+1
+0% +$82 0.86% 31
2025
Q2
$21.5M Buy
268,432
+267,437
+26,878% +$21.3M 0.88% 30
2025
Q1
$89.3K Buy
+995
New +$92.9K 0.47% 33

Other funds holding MRK

Saudi Central Bank's MRK Position: Q2 2026 in Review

Saudi Central Bank increased its Merck (MRK) stake by 23% in Q2 2026, buying an estimated $9.53M and bringing the position to 440,465 shares worth $56.3M. The position accounts for 0.74% of the portfolio, ranked #29.

Saudi Central Bank first reported a position in MRK in Q1 2025 and has held it in 6 quarters since. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Saudi Central Bank held 440,465 shares of Merck worth $56.3M as of Q2 2026.
  • Saudi Central Bank bought 81,454 Merck shares in Q2 2026, an estimated $9.53M.
  • Merck made up 0.74% of Saudi Central Bank's portfolio in Q2 2026, its #29 holding.
  • Saudi Central Bank first reported a position in Merck in Q1 2025 and has held it in 6 quarters since.
  • 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Saudi Central Bank's 13F filing for Q2 2026, filed 30 Jul 2026.